posted on 2015-09-30, 04:12authored bySvenja Thies, Martina Friess, Lukas Frischknecht, Dimitri Korol, Emanuela Felley-Bosco, Rolf Stahel, Bart Vrugt, Walter Weder, Isabelle Opitz, Alex Soltermann
In cohort 2, the distribution of immunohistochemical H-scores (intensity of immunoreactivity multiplied by frequency of stained cells) is indicated for both pre-and post-chemotherapy (pre-CT/post-CT) biopsies and surgical specimens, respectively. amodified RECIST criteria were only available for 97 patients.
Summary of clinico-pathological and immunohistochemical data.